Shopping Cart
Remove All
Your shopping cart is currently empty
Efzimfotase alfa is an enzyme replacement therapy targeting tissue non-specific alkaline phosphatase (TNSALP) deficiency. By hydrolyzing substrates of TNSALP, Efzimfotase alfa reduces concentrations of substrates such as inorganic pyrophosphate (PPi) and pyridoxal 5'-phosphate (PLP). It is being investigated for its potential use in hypophosphatasia (HPP).
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | Inquiry | Inquiry | Inquiry | |
| 5 mg | Inquiry | Inquiry | Inquiry |
| Description | Efzimfotase alfa is an enzyme replacement therapy targeting tissue non-specific alkaline phosphatase (TNSALP) deficiency. By hydrolyzing substrates of TNSALP, Efzimfotase alfa reduces concentrations of substrates such as inorganic pyrophosphate (PPi) and pyridoxal 5'-phosphate (PLP). It is being investigated for its potential use in hypophosphatasia (HPP). |
| Synonyms | ALXN-1850 |
| Reactivity | Human |
| Application | FACS Functional assay |
| Antibody Type | Monoclonal |
| Endotoxin | < 1.0 EU/mg |
| Conjucates | Unconjugated |
| Target | TNSALP |
| Cas No. | 2746354-58-3 |
| Storage | store at low temperature | -20°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.